ArticleMarine drugs2019

Fucoidan Prevents RANKL-Stimulated Osteoclastogenesis and LPS-Induced Inflammatory Bone Loss via Regulation of Akt/GSK3β/PTEN/NFATc1 Signaling Pathway and Calcineurin Activity.

Sheng-Hua Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.